Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands		9 Months Ended
		Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net income		$ 289,522	$ 269,347
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		165,841	114,809
Deferred income taxes		37,094	29,767
Loss (gain) on disposition of assets		1,274	(890)
Share-based compensation		32,908	27,707
Excess tax benefit from share-based compensation		(3,693)	(3,204)
Non-cash interest expense		2,097	2,242
Non-cash (decrease) increase in contingent consideration		(5,309)	1,016
(Increase) decrease in:
Receivables, net		(63,054)	(142,805)
Inventories		(145,364)	(139,094)
Other current assets		(35,478)	(42,251)
Pre-production and development costs		(41,247)	(8,395)
(Decrease) increase in:
Accounts payable		(138,781)	182,498
Accrued warranties		7,326	29,573
Accrued other liabilities		16,770	78,978
Income taxes payable		(45,906)	9,662
Net change in derivative assets and liabilities		4,104	(66,283)
Other operating activities		3,382	(37,302)
Net cash provided by operating activities		81,486	305,375
Cash flows from investing activities:
Acquisitions, net of cash received		(226,841)	(118,021)
Capital expenditures		(139,850)	(108,488)
Proceeds from asset dispositions		120	4,548
Other items, net		2,550	549
Net cash used in investing activities		(364,021)	(221,412)
Cash flows from financing activities:
(Decrease) in short-term borrowings		(182)	(963)
Borrowings of long-term debt		232,627	593,448
Repayments of long-term debt		(35,125)	(543,610)
Cash dividends to shareholders		(75,517)	(68,631)
Repurchase of common stock		(74,717)
Exercise of stock options		6,102	23,066
Repurchases related to share-based compensation arrangements		(11,932)	(22,272)
Excess tax benefit from share-based compensation		3,693	3,204
Debt issuance costs			(3,019)
Payment of contingent consideration		(27,138)	(327)
Repayments of acquiree debt		(2,572)	(5,612)
Purchase of non-controlling interest		(17,133)
Other items, net		(762)	10,244
Net cash used in financing activities		(2,656)	(14,472)
Effect of exchange rate changes on cash		(3,902)	(58,444)
Net (decrease) increase in cash and cash equivalents		(289,093)	11,047
Cash and cash equivalents at beginning of period		649,513	581,312
Cash and cash equivalents at end of period		360,420	592,359
Supplemental disclosure of cash flow information:
Interest paid, net		12,403	6,363
Income taxes paid		77,981	13,290
Non-cash investing activities:
Accrued and contingent acquisition-related liabilities		$ 24,938	31,003
Common stock issued in connection with acquisitions	[1]		$ 124,253

[1] Refer to Note 22 – Acquisitions for more information.